NCT06370273View on ClinicalTrials.gov

Thromboprophylaxis in Lower Limb Immobilisation

PHASE3RecruitingINTERVENTIONAL
Enrollment

10,044

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

August 31, 2028

Study Completion Date

August 31, 2028

Conditions
ThrombosisInjury Leg
Interventions
DRUG

Rivaroxaban

10mg once daily via oral ingestion

DRUG

Apixaban

2.5mg twice daily via oral ingestion

DRUG

Enoxaparin Injectable Solution

40mg once daily via subcutaneous injection

DRUG

Tinzaparin Injectable Solution

4500 IU once daily via subcutaneous injection

DRUG

Dalteparin Injectable Solution

5000 IU once daily via subcutaneous injection

DRUG

Fondaparinux Injectable Product

2.5 mg once daily via subcutaneous injection

Trial Locations (3)

Unknown

RECRUITING

Epsom and St Helier University Hospitals NHS Trust, Carshalton

RECRUITING

Barts Health NHS Trust, London

RECRUITING

Northern Care Alliance NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Queen Mary University of London

OTHER